Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Opłaty publikacyjne
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
1/2023
vol. 125 streszczenie artykułu:
Opis przypadku
Idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN): a case report and outcomes of 1.5-year observation
Marta Świerczyńska
1, 2
,
Lech Sedlak
1, 2
,
Paweł Wąs
1, 2
,
Marta Nowak
1, 2, 3
,
Mariola Dorecka
1, 2
,
Ewa Mrukwa-Kominek
1, 2
KLINIKA OCZNA 2023, 125, 1: 50-55
Data publikacji online: 2022/09/06
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction Idiopathic retinal vasculitis, aneurysms and neuro- retinitis (IRVAN) syndrome is a rare clinical entity of unknown etiology with vision threatening potentials. Case presentation In this article, we present a case of a 38-year-old woman complaining of decreased visual acuity OU (oculi utriusque) for a duration of 3 months. On admission, the best-corrected visual acuity (BCVA) was 5/50 in the right eye (RE) and 2/50 in the left eye (LE). Mild rubeosis iridis in the LE was noted. Posterior segment examination revealed hemorrhage floaters in the vitreous chamber, macular edema, hemorrhages and aneurysms in OU. Fundus fluorescein angiography (FFA) showed the presence of numerous microaneurysms, enhancement of vascular contrast, leakage on the optic nerve disc, as well as extensive areas of non-perfusion in the middle peripheral retina in OU. Based on constellation of clinical and angiographic features as well as the negative extensive workup, a diagnosis of IRVAN was established. Anti-inflammatory, immunosuppressive and hemostatic treatments were applied, and panretinal photocoagulation was performed in OU. In the next stage, due to visual impairment, persistent vascular leak, macular edema in OU, anti-vascular endothelial growth factor (VEGF) intravitreal injections were given. As a result, BCVA increased to 5/12 in the RE and 5/50 in the LE. The patient remains under regular follow-up. Conclusions Late diagnosis and lack of appropriate treatment of IRVAN syndrome may lead to complete loss of vision due to complications secondary to lack of perfusion. It is important for ophthalmologists to improve understanding of this disease and manage the symptoms as soon as possible. |
|